-
公开(公告)号：US09296783B2
公开(公告)日：2016-03-29
申请号：US14024961
申请日：2013-09-12
申请人： Ipsen Pharma S.A.S.
摘要： The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
-
公开(公告)号：US20240182519A1
公开(公告)日：2024-06-06
申请号：US18142621
申请日：2023-05-03
申请人： IPSEN PHARMA S.A.S.
摘要： The present invention relates to peptide ligands of the melanocortin receptors, in particular the melanocortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
-
公开(公告)号：US20210163536A1
公开(公告)日：2021-06-03
申请号：US17166756
申请日：2021-02-03
申请人： IPSEN PHARMA S.A.S.
摘要： The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
-
公开(公告)号：US09758549B2
公开(公告)日：2017-09-12
申请号：US15055873
申请日：2016-02-29
申请人： Ipsen Pharma S.A.S.
摘要： The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
-
公开(公告)号：US20190062374A1
公开(公告)日：2019-02-28
申请号：US16186879
申请日：2018-11-12
申请人： Ipsen Pharma S.A.S.
摘要： The present invention relates to peptide ligands of the melanocortin receptors, in particular the melancortin-4 receptor, and as such, are useful in the treatment of disorders responsive to the activation of this receptor, such as obesity, diabetes mellitus and sexual dysfunction.
-
-
-
-
搜索结果
5 条记录 (耗时 0.013 秒)
